Valuation for Hyloris Pharmaceuticals SA (id:380 HYL)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -9.49 |
|
|
| Forward P/E | -8.28 |
|
|
| Price to sales | 20.25 |
|
|
| Price to book | 4.21 |
|
|
| Enterprise to revenue | 17.25 |
|
|
| Enterprise to ebitda | -8.85 |
|
|